BriendleyG. S.: Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence. Brit. J. Psychiat., 143; 332 (1983).
2.
KarakanI.: Clinical value of nocturnal erection in the diagnosis and prognosis of impotence. Med. Aspect Human Sexuality, 4; 25 (1970).
3.
LueT. F., HricakH., MarichW. K., TanaghoE. A.: Evaluation of arteriogenic impotence with intracorporal injection of papaverine and the duplex ultrasound scanner. Seminar in Urology, vol. 3, No I; 43–48 (1985).
4.
MichalV., KramarR., PospichalJ.: Arterial epigastricocavernous anastomosis for the treatment of sexual impotence. Wordl J. Surg., 1; 515–520 (1977).
5.
NeedlemanP., JohnsonE. M.jr.: Vasodilatators and the treatment of angina. In: The pharmacological basis of therapeutics. 6th ed. GoodmanA. G.GoodmanL. S., GilmanA. Z. (edrs). McMillan Publ. Co., sect. IV, 33; 830, New York1980.
6.
ViragR.: Intracavernous injection of papaverine for erectile failure. Letter to the Editor. Lancet, 2; 938 (1982).
7.
ViragR., FrydmanD., LegmanM.: Intracavernous injection of papaverine ss a diagnostic and therapeutic method in erectile failure. Angiology, 35; 79–87 (1984).
8.
ViragR., ViragH.: L'épreuve à la papavérine intracaverneuse dans l'étude de l'impuissance. Perspectives thérapeutiques. J. Maladies Vasculaires, 8; 293–295 (1983).
9.
ViragR., ViragH., LajugieJ.: A new device for measuring penile rigidity. IVme Conference sur la revascularisation des corps caverneux, Copenhagen 1982.
10.
ZorgniottiA. V., LefleurR. S.: Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. J. Urol., 133; 39–41 (1985).